Literature DB >> 8414521

Specific association of activated MAP kinase kinase kinase (Raf) with the plasma membranes of ras-transformed retinal cells.

S Traverse1, P Cohen, H Paterson, C Marshall, U Rapp, R J Grand.   

Abstract

Plasma membrane-enriched fractions were prepared from human embryonic retinal cells transformed with either adenovirus E1A and oncogenic ras DNA, or E1A and E1B DNA. Ras comprised 5-10% of the membrane protein from the E1A/ras transformed cells, whereas the membranes from E1A/E1B transformed cells did not overexpress Ras. The membranes from E1A/ras cells contained MAP kinase kinase kinase (MAPKKK) activity, even after washing in 0.5 M NaCl, whereas the membranes from E1A/E1B cells did not. Neither membrane fraction contained MAP kinase kinase or MAP kinase activity after washing with 0.5M NaCl. Immunoblotting experiments revealed about 10-fold more c-Raf in the membranes from E1A/ras cells than from E1A/E1B cells, and 50-60% of the MAPKKK activity in Triton X100-solubilised membranes from E1A/ras cells was immunoprecipitated with anti-Raf antibodies. A striking enrichment of c-Raf in the plasma membranes of E1A/ras cells was also demonstrated by immunocytochemistry, where it was co-localized with Ras. The MAPKKK activity in E1A/ras membranes was unaffected by incubation with protein phosphatases or by inclusion of protein phosphatase inhibitors during isolation, nor was it activated by GTP-Ras or inhibited by GDP-Ras. The results support the view that Ras and c-Raf interact with one another, but that neither c-Raf phosphorylation nor its interaction with GTP-Ras are alone sufficient for activation. The identification of MAPKKK activity in the membranes of ras-transformed cells may prove useful in elucidating the mechanism by which Raf is activated by Ras.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8414521

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  31 in total

1.  S338 phosphorylation of Raf-1 is independent of phosphatidylinositol 3-kinase and Pak3.

Authors:  A Chiloeches; C S Mason; R Marais
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation.

Authors:  C S Mason; C J Springer; R G Cooper; G Superti-Furga; C J Marshall; R Marais
Journal:  EMBO J       Date:  1999-04-15       Impact factor: 11.598

3.  Activation of the Raf/MAP kinase cascade by the Ras-related protein TC21 is required for the TC21-mediated transformation of NIH 3T3 cells.

Authors:  M Rosário; H F Paterson; C J Marshall
Journal:  EMBO J       Date:  1999-03-01       Impact factor: 11.598

4.  H-Ras signaling and K-Ras signaling are differentially dependent on endocytosis.

Authors:  Sandrine Roy; Bruce Wyse; John F Hancock
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

5.  The mammalian mitogen activated protein kinase network.

Authors:  P Lenormand
Journal:  Clin Mol Pathol       Date:  1995-12

6.  14-3-3 facilitates Ras-dependent Raf-1 activation in vitro and in vivo.

Authors:  S Roy; R A McPherson; A Apolloni; J Yan; A Lane; J Clyde-Smith; J F Hancock
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

7.  Activation of a protein tyrosine phosphatase and inactivation of Raf-1 by somatostatin.

Authors:  D B Reardon; S L Wood; D L Brautigan; G I Bell; P Dent; T W Sturgill
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

8.  Activation of c-Raf-1 by Ras and Src through different mechanisms: activation in vivo and in vitro.

Authors:  D Stokoe; F McCormick
Journal:  EMBO J       Date:  1997-05-01       Impact factor: 11.598

9.  Negative regulation of Raf-1 by phosphorylation of serine 621.

Authors:  H Mischak; T Seitz; P Janosch; M Eulitz; H Steen; M Schellerer; A Philipp; W Kolch
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

10.  Destabilization of Raf-1 by geldanamycin leads to disruption of the Raf-1-MEK-mitogen-activated protein kinase signalling pathway.

Authors:  T W Schulte; M V Blagosklonny; L Romanova; J F Mushinski; B P Monia; J F Johnston; P Nguyen; J Trepel; L M Neckers
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.